Loophole fuels US 'wild west' of untested peptide drugs
A regulatory loophole allows companies to sell unapproved peptides, often marketed as anti-aging or performance-enhancing drugs, without FDA oversight. Consumers can easily obtain these untested substances, raising serious safety concerns. This underscores the need for stricter enforcement to protect public health.